Question 1

How many shares of AMRX does Connor, Clark & Lunn Investment Management Ltd. own?

Accepted Answer

Connor, Clark & Lunn Investment Management Ltd. previously held 0 shares of AMRX (AMNEAL PHARMACEUTICALS INC) before exiting the position in 2025-Q4.

Question 2

What is Connor, Clark & Lunn Investment Management Ltd.'s AMRX position worth?

Accepted Answer

Connor, Clark & Lunn Investment Management Ltd.'s AMRX position was last reported at $0 in 2025-Q4 before the exit.

Question 3

Is Connor, Clark & Lunn Investment Management Ltd. buying or selling AMRX?

Accepted Answer

In 2025-Q4, Connor, Clark & Lunn Investment Management Ltd. exited their AMRX position entirely (-100.0% change in shares).

Question 4

When did Connor, Clark & Lunn Investment Management Ltd. first buy AMRX?

Accepted Answer

Based on available 13F filings, Connor, Clark & Lunn Investment Management Ltd. first reported a position in AMRX in 2024-Q3. They have held the position across 18 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$12.88	0
2025-Q3	Increased	623,258	+3.5%	$6.2M	0.0%	$9.87	28
2025-Q2	Increased	602,468	+14.2%	$4.9M	0.0%	$8.13	31
2025-Q1	Decreased	527,685	-5.0%	$4.4M	0.0%	$8.28	0
2024-Q4	Increased	555,655	+1.2%	$4.4M	0.0%	$7.83	27
2024-Q3	Decreased	548,975	-1.6%	$4.6M	0.0%	$8.19	0